Piperazine

Piperazine

SCHEMBL9028861

C1CNCCN1.COCCC1CN(Cc2ccccc2)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.42
NR1H3 Q13133 2/20 0.42
SIGMAR1 Q99720 1/20 0.42
PARP1 P09874 1/20 0.42
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA4 P22748 4/20 0.41
CA9 Q16790 4/20 0.41
HDAC1 Q13547 1/20 0.39
LMNA P02545 1/20 0.39
AGTR2 P50052 1/20 0.39
ACHE P22303 1/20 0.38
DPP4 P27487 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL9028864 1.00 NR1H2 (0.42) NR1H2NR1H3SIGMAR1PARP1CA1
SCHEMBL8394418 0.95 NR1H2 (0.46) NR1H2NR1H3SIGMAR1PARP1CA1
SCHEMBL8394421 0.95 NR1H2 (0.46) NR1H2NR1H3SIGMAR1PARP1CA1
Piperazine SCHEMBL9028956 0.90 CA1 (0.52) NR1H2NR1H3SIGMAR1CA1CA2
Piperazine SCHEMBL9028960 0.90 CA1 (0.52) NR1H2NR1H3SIGMAR1CA1CA2
SCHEMBL8571416 0.89 NR1H2 (0.44) NR1H2NR1H3SIGMAR1PARP1CA1
SCHEMBL4846692 0.85 NR1H2 (0.44) NR1H2NR1H3SIGMAR1PARP1CA1
SCHEMBL4846682 0.85 NR1H2 (0.44) NR1H2NR1H3SIGMAR1PARP1CA1
SCHEMBL15020095 0.84 NR1H2 (0.47) NR1H2NR1H3SIGMAR1PARP1CA1
SCHEMBL8229902 0.84 CA1 (0.56) NR1H2NR1H3SIGMAR1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0703905-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO. INC. (US) 1996-04-03 EP disclosed